Passion's Caviezel, sports stars oppose stem cell research in new Missouri TV ad

Ron Brynaert
Published: Wednesday October 25, 2006

Print This  Email This

A new television advertisment opposing stem cell research is scheduled to air tonight in Missouri, which features Jim Caviezel, star of Mel Gibson's The Passion of the Christ, former Everybody Loves Raymond actress Patricia Heaton, and some of the state's biggest sports stars, RAW STORY has found.

The ad was created in response to an ad for Democratic Senate candidate Claire McCaskill featuring Michael J. Fox, whose acting career was largely halted after he was diagnosed with Parkinson's disease, which many scientists believe stem cell research can aid in curing or treating. McCaskill is urging voters to vote for the Missouri Stem Cell Research and Cures Initiative (Amendment 2) in November.

One of the sports stars featured, National League championship series MVP Jeff Suppan of the St. Louis Cardinals, is scheduled to pitch in tonight's World Series game against the Detroit Tigers. The Cardinals lead the Tigers two games to one in the best of seven series.

"Amendment 2 claims that it bans human cloning," Suppan says in the ad, "but in the 2,000 words you won't read it makes cloning a constitutional right."

"Don't be decieved," Suppan says.

Former St. Louis Rams quarterback Kurt Warner, the MVP for Super Bowl XXXIV, and Mike Sweeney, a designated hitter for the Kansas City Royals, are also featured in the ad, produced by a group called Missourians Against Human Cloning.

Connie Farrow, a spokeswoman for Missouri Coalition for Lifesaving Cures, told the Associated Press that the "anti-Fox" ad was a pathetic attempt to distort the facts and mislead voters."

As of noon today, the group's ad, which was placed on YouTube, has received over 170,000 viewings.

"At least in the advance version shown on YouTube last night, Mr. Caviezelís introduction seemed either garbled or to be in Aramaic," Alessandra Stanley observes in Wednesday's edition of The New York Times.